# Adaptimmune Therapeutics PLC: Form SCHEDULE 13D/A, filed Aug 19, 2025

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: SCHEDULE 13D/A
- Filed: 2025-08-19
- Accepted by EDGAR: Aug 19, 2025, 18:53 ET
- Period: not reported
- Accession: 0001072613-25-000670
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000107261325000670/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000107261325000670/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000107261325000670/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001072613-25-000670. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
